# University of Otago

Organization · id `cardio:org-university-of-otago` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 01jmxt844](<https://ror.org/01jmxt844>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 01jmxt844 by an exact name.

## The registry's words

- Sponsor name: University of Otago
- Sponsor class: OTHER
- ROR name: University of Otago

## Connected pages

- Sponsors: Renal Denervation in Heart Failure Patients With Preserved Ejection Fraction (RESPECT-HF) (`cardio:ct-nct02041130`)
- Sponsors: Mineralocorticoid Antagonism to Stop Progression of Atrial Fibrillation (MONITOR-AF) Study (`cardio:ct-nct04327232`)
- Sponsors: PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE (`cardio:ct-nct04601467`)

## Provenance

Content hash: 75ec257e90553c7d5f3c1371c5411cedcd6138bb3100af6091baffe74d5d5bf5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
